Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.

Steiner H, Geist M, Goldenberg I, Suleiman M, Glikson M, Tenenbaum A, Swissa M, Fisman EZ, Golovchiner G, Strasberg B, Barsheshet A; Israeli Working Group of Pacing and EP.

Cardiovasc Diabetol. 2016 Dec 1;15(1):160.

2.

Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Khazanie P, Greiner MA, Al-Khatib SM, Piccini JP, Turakhia MP, Varosy PD, Masoudi FA, Curtis LH, Hernandez AF; National Cardiovascular Data Registry.

Circ Heart Fail. 2016 Jun;9(6). pii: e002324. doi: 10.1161/CIRCHEARTFAILURE.115.002324.

3.

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.

Khazanie P, Hellkamp AS, Fonarow GC, Bhatt DL, Masoudi FA, Anstrom KJ, Heidenreich PA, Yancy CW, Curtis LH, Hernandez AF, Peterson ED, Al-Khatib SM.

J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.

4.

Same-day discharge and risks of mortality and readmission after elective ICD placement for primary prevention.

Hess PL, Greiner MA, Al-Khatib SM, Masoudi FA, Varosy PD, Fogel RI, Curtis LH, Hernandez AF.

J Am Coll Cardiol. 2015 Mar 10;65(9):955-7. doi: 10.1016/j.jacc.2014.12.032. No abstract available.

5.

Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.

Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):179-86. doi: 10.1161/CIRCOUTCOMES.114.001306. Epub 2015 Feb 10.

6.

Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA.

Circulation. 2014 Sep 2;130(10):845-53. doi: 10.1161/CIRCULATIONAHA.114.008653. Epub 2014 Aug 5.

7.

Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.

Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Hess PL, Inoue LY, Sanders GD.

Am J Kidney Dis. 2014 Jul;64(1):32-9. doi: 10.1053/j.ajkd.2013.12.009. Epub 2014 Feb 8.

8.

Device therapy: increased number of complications with dual-chamber ICDs.

Cully M.

Nat Rev Cardiol. 2013 Jul;10(7):364. doi: 10.1038/nrcardio.2013.87. Epub 2013 Jun 4. No abstract available.

PMID:
23736521
9.

Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention.

Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SL, Masoudi FA.

JAMA. 2013 May 15;309(19):2025-34. doi: 10.1001/jama.2013.4982.

10.

Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.

Van Boven N, Bogaard K, Ruiter J, Kimman G, Theuns D, Kardys I, Umans V.

J Cardiovasc Electrophysiol. 2013 Mar;24(3):316-22. doi: 10.1111/jce.12037. Epub 2012 Dec 4.

PMID:
23210664

Supplemental Content

Loading ...
Support Center